Login to Your Account

Improving Trial Efficiency in Face of Rising Costs

FDA Proposes Framework for Patient Enrichment Strategies

By Marie Powers
Staff Writer

Wednesday, March 27, 2013
With the cost of clinical trials climbing, the FDA is worried about its ability to obtain sufficient information to make determinations about safety and efficacy claims when examining new drug applications and biologics license applications.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription